NCT03823690View on ClinicalTrials.gov

EPASS Versus Uncovered Duodenal Stent for Unresectable Malignant Gastric Outlet Obstruction.

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

May 30, 2022

Study Completion Date

May 30, 2022

Conditions
Gastric Outlet Obstruction
Interventions
DEVICE

EUS-guided gastrojejunstomy

As listed in the arms description

DEVICE

The pyloro-duodenal stent

As listed in the arms description

Trial Locations (1)

Unknown

Department of Surgery, Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT03823690 - EPASS Versus Uncovered Duodenal Stent for Unresectable Malignant Gastric Outlet Obstruction. | Biotech Hunter | Biotech Hunter